Your position:www.healthoo.com >> EN >> EN >> Formulation >> India Poised to Become Global Hub for Clinical Trials with Major Investment Plans >> article
 
India Poised to Become Global Hub for Clinical Trials with Major Investment Plans
Editor:xuezhe     Clicks:29    Date:2025/2/28 15:54:10
Keyword: India
Healthoo Information:
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName 
Contact:  Title: Mr.Ms.
Password  
Repeat password: 
Mobile 
Email 
Verification code: 
Company Name 
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68012929
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • Key events of India PLI plan in pharmaceutical industry in 2024.
  • Indian Pharmaceutical Market Grows 6.1% in October Against the Trend
  • On August 21st, an explosion occurred in a pharmaceutical factory in I...
  • Indian Pharmaceuticals Focus on American Market
  • Top 10 countries accounted for Indias 63% of Ayush herbal products exp...
  • Indias bulk drug imports grow 4.12% in 2023-24, imports from China acc...
  • What are the changes in the export of domestic pharmaceutical intermed...
  • Indian API industry: Current trends future ahead
  • India’s mental healthcare grapples with stigma, inadequate resources &...
  • Indias Quest for Pharma Self-Sufficiency: Reducing Dependence on China
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463